Elicio Therapeutics Inc.
08/30/2024 | Press release | Distributed by Public on 08/30/2024 06:30
Management Change/Compensation Form 8 K
Item 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the "Company"), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity. Mr. Piekos' resignation is not the result of any disagreement with the Company on any matter related to the Company's financial reporting or accounting policies, procedures, estimates or judgments. The Company thanks Mr. Piekos for his service and wishes him well. The Company has initiated a search for a new Chief Financial Officer.